Neural cell repopulation is the process of replenishing dead or damaged neurons with new neurons produced from stem cells. This process has been the subject of intense research in recent years due to its potential for correcting neurological damage caused by stroke, spinal cord injury, and other brain diseases. Neural cell repopulation involves the implantation of neural stem and progenitor cells (NS&PCs) into the damaged brain tissue. The implantation of NS&PCs into the injured brain area has been shown to cause the formation of new neurons, providing potential for the treatment of neurodegenerative disorders. The process of repopulating neural cells is initiated through the growth of NS&PCs in culture and in an appropriate extracellular matrix, such as hydrogels. These cells, in turn, can be modified or genetically engineered in laboratory settings in order to induce desired characteristics in the repopulating neurons. Additionally, growth factors have been demonstrated to promote the survival and activity of these cells following transplantation into an injured brain. In addition to the production of new neurons, strategies for neural cell repopulation also involve the stimulation of existing neural cells and the restoration of their connections to the neuronal network. To achieve this, micro-electrodes have been implanted to deliver electrical stimulation to the area of damage, which can help to maintain the function of the existing neurons. Furthermore, techniques such as tissue engineering and gene therapy have also been used in order to promote the connectivity of neurons and the structural and functional organization of the brain. Overall, although much progress has been made in the field of neural cell repopulation, further research is necessary to create successful clinical therapies. Additionally, the potential of this technology needs to be further explored in order to help restore damaged areas of the brain and potentially prevent further neurological damage.
Title : Perception and individuality in patient cases identifying the ongoing evolution of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
Ken Ware, NeuroPhysics Therapy Institute, Australia
Title : Narrative medicine: A communication therapy for the communication disorder of Functional Seizures (FS) [also known as Psychogenic Non-Epileptic Seizures (PNES)]
Robert B Slocum, University of Kentucky HealthCare, United States
Title : Personalized and Precision Medicine (PPM), as a unique healthcare model through biodesign-driven biotech and biopharma, translational applications, and neurology-related biomarketing to secure human healthcare and biosafety
Sergey Victorovich Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Neuro sensorium
Luiz Moutinho, University of Suffolk, United Kingdom
Title : GBF1 inhibition reduces amyloid-beta levels in viable human postmortem Alzheimer's disease cortical explant and cortical organoid models
Sean J Miller, Yale School of Medicine, United States
Title : Traumatic Spinal Cord Injuries (tSCI) - Are the radiologically based “advances” in the management of the injured spine evidence-based?
W S El Masri, Keele University, United Kingdom